The deal priced below last closing price of $4.51. ThinkEquity is acting as sole book running manager for the offering.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVM:
- CEL-SCI announces common stock offering, no amount given
- CEL-SCI completes Breakthrough Medicine Designation application for Multikine
- CEL-SCI expects 1 for 30 combination of common stock to be implemented on May 20
- CEL-SCI says publication supports strategy to seek early approval for multikine
- CEL-SCI publishes new data from Multikine study